PRESS RELEASE
13 June 2025

A&O Shearman Advises L'Oréal Groupe On Its Acquisition Of A Majority Stake In Medik8

AO
A&O Shearman

Contributor

A&O Shearman was formed in 2024 via the merger of two historic firms, Allen & Overy and Shearman & Sterling. With nearly 4,000 lawyers globally, we are equally fluent in English law, U.S. law and the laws of the world’s most dynamic markets. This combination creates a new kind of law firm, one built to achieve unparalleled outcomes for our clients on their most complex, multijurisdictional matters – everywhere in the world. A firm that advises at the forefront of the forces changing the current of global business and that is unrivalled in its global strength. Our clients benefit from the collective experience of teams who work with many of the world’s most influential companies and institutions, and have a history of precedent-setting innovations. Together our lawyers advise more than a third of NYSE-listed businesses, a fifth of the NASDAQ and a notable proportion of the London Stock Exchange, the Euronext, Euronext Paris and the Tokyo and Hong Kong Stock Exchanges.
A&O Shearman is proud to announce its role advising L'Oréal Groupe on its acquisition of a majority stake in the British premium skincare brand Medik8.
United States

A&O Shearman is proud to announce its role advising L'Oréal Groupe on its acquisition of a majority stake in the British premium skincare brand Medik8. As part of the transaction, Inflexion, a leading European mid-market private equity firm, will remain a minority shareholder. The founder will continue to serve on the board, with the current management committee also remaining in place to ensure continuity.

Founded by Elliot Isaacs, Medik8 is best known for its iconic Crystal Retinal serum and its trademark CSA Philosophy©: Vitamin C and Sunscreen by Day, Vitamin A by night. Driven by scientific research and innovation, the brand offers ingredient-led premium skincare to deliver "results without compromise." Still true to its professional origins, the brand has also evolved towards a diversified omni-channel sales mix across the most prominent online and offline retailers in Europe, with a growing presence in the U.S.

This acquisition further strengthens L'Oréal's Luxe portfolio, adding a premium, science-backed skincare brand with a proven track record of success and strong potential for global growth. The transaction, which is subject to regulatory approvals and other customary conditions, is expected to complete in the next few months. As part of the agreement, L'Oréal has also secured rights to buyout in full the minority shareholders.

This transaction highlights A&O Shearman's position as a global leader in consumer M&A, following recent high-profile mandates across the sector.

The L'Oréal legal team was led by Arnaud de Rochebrune, general counsel M&A, Financing and Licenses, and Guillaume Regnier, associate general counsel M&A.

The A&O Shearman team was led by M&A partners Matthew Appleton and Aoife McDermott supported by senior associate Antony Dean, associates Arabella Robinson and Toluwa Agboola, and trainee Asfia Mohsin.

Incentives advice was provided by partner Mahesh Varia with support from associate Betty Lorimer. Tax advice was provided by partners Lydia Challen and Guillaume Valois, with senior associate Charlotte Signol and associate Geraldine Chan across our London and Paris offices. Antitrust advice was provided by partner Thomas Masterman and senior associate Lindsay Morison in London and partner Elaine Johnston with associates Kiko Demetriou and Regina Loureiro in New York and Washington D.C.

Contributor

A&O Shearman was formed in 2024 via the merger of two historic firms, Allen & Overy and Shearman & Sterling. With nearly 4,000 lawyers globally, we are equally fluent in English law, U.S. law and the laws of the world’s most dynamic markets. This combination creates a new kind of law firm, one built to achieve unparalleled outcomes for our clients on their most complex, multijurisdictional matters – everywhere in the world. A firm that advises at the forefront of the forces changing the current of global business and that is unrivalled in its global strength. Our clients benefit from the collective experience of teams who work with many of the world’s most influential companies and institutions, and have a history of precedent-setting innovations. Together our lawyers advise more than a third of NYSE-listed businesses, a fifth of the NASDAQ and a notable proportion of the London Stock Exchange, the Euronext, Euronext Paris and the Tokyo and Hong Kong Stock Exchanges.

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More